Objective: Thalassemia syndrome is a heterogeneous group of hereditary disorders affecting the synthesis of globin chains of adult hemoglobin's, leading to ineffective erythropoiesis, hemolysis, and moderate to severe anemia. The study aimed to identify the incidence of osteopenia and osteoporosis among thalassemia patients. Study Design: A cross-section observational study Place and Duration of Study: September 2020 to April 2021, enrolled 50 patients attended Thalassemia Center. Methods: Twenty-four patients were male and 26 were female. They were scanned for bone mass density (BMD) at lumbar spine with dualenergy X-ray absorptiometry (DEXA). Blood samples collected for the estimation of serum ferritin, vitamin D3 and Hb levels. Results: Ninety-percent of cases were B-thalassemia major type (BTHM), while 5 patients (10%) had B-thalassemia intermedia (THI). Majority of cases had age at first diagnosis were below five-year age. Osteopenia was higher in number and severity among THM patients than THI patients 35(70%) vs. 4(8%) respectively, as well as osteoporosis found in 9(18%) in THM patients, while none in THI patients. In relation to Z-score change (before and after therapy) among age groups, in both groups the number of osteopenia cases reduced, while increased of osteoporosis, besides, increased severity with significant difference (p=0.02). Conclusions: This is a predominance of osteopenia over osteoporosis in spite of therapy, mainly in thalassemia major. The severity of bone density reduction correlates insignificantly with younger age at diagnosis, deficiency of vitamin D3, lower Hb level, high S. ferritin and significantly correlates with increasing age.